Proliferative arrest and cell cycle regulation in CD8 +CD28 − versus CD8 +CD28 + T cells

Abstract

CD8 +CD28 − T cells have been characterized by oligoclonal expansions, impaired proliferative responses, but preserved cytotoxicity and reduced telomeres. To examine this subset further and define the underlying mechanisms of proliferation arrest, we investigated several features of this cell type compared with CD8 +CD28 + controls. We analyzed expression of various activation markers, thymidine incorporation upon activation, T-cell receptor (TCR) ζ-chain phosphorylation, cell cycle characteristics, and cell cycle related gene expression. Flow cytometry revealed higher expression of CD11b, CD29, CD57, and CD94, and lower expression of CD25 in CD8 +CD28 − compared with CD8 +CD28 + T cells. Sorted CD8 +CD16 −CD28 − cells exhibited decreased phosphorylation of the TCR ζ-chain in three of four probands. Proliferation of these T cells was impaired, even when activated with mitogens that bypass TCR signaling. Cell cycle profiles demonstrated a lower percentage of cycling cells and significantly higher levels of cyclin dependent kinase inhibitor p16 INK4a in the CD28 − subset compared with the CD28 + control. These observations suggest that expanded CD8 +CD28 − T cells in normal elderly individuals have reduced proliferation concomitant with increased p16 INK4a expression. Defects in TCR signaling were associated with altered TCR ζ-chain phosphorylation.